Harry Iland
- Hematology top 1%
- Acute Myeloid Leukemia Research 25
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 6
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 7
- Rheumatology top 10%
- Oncology top 10%
-
- Retinoids in leukemia and cellular processes 14
- Advanced biosensing and bioanalysis techniques 6
-
- Lymphoma Diagnosis and Treatment 9
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- John LászlóDavid S. H. RosenthalSeamus MurphyJohn GibsonAlberto CatalanoJohn F. SeymourChristina BrownP. Joy Ho
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Harry Iland
60 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Hematology 838
- Genetics 550
- Rheumatology 161
- Oncology 260
- Molecular Biology 591
Countries citing papers authored by Harry Iland
This map shows the geographic impact of Harry Iland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Iland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Iland more than expected).
Fields of papers citing papers by Harry Iland
This network shows the impact of papers produced by Harry Iland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Iland. The network helps show where Harry Iland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harry Iland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2019 | 7 | |
| 5 | 2017 | 65 | |
| 6 | 2014 | 15 | |
| 7 | 2013 | 7 | |
| 8 | 2012 | 11 | |
| 9 | 2011 | 42 | |
| 10 | 2011 | 103 | |
| 11 | 2006 | 14 | |
| 12 | 2006 | 11 | |
| 13 | 2002 | 9 | |
| 14 | 1999 | 4 | |
| 15 | 1994 | 15 | |
| 16 | 1991 | 58 | |
| 17 | 1991 | 13 | |
| 18 | 1991 | 14 | |
| 19 | 1989 | 13 | |
| 20 | 1987 | 46 |
About Harry Iland
Harry Iland is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 61 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (25 papers), Retinoids in leukemia and cellular processes (14 papers), Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Hematology (838 citations), Genetics (550 citations) and Rheumatology (161 citations). Harry Iland has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include John László, David S. H. Rosenthal, Seamus Murphy, John Gibson, Alberto Catalano, John F. Seymour, Christina Brown, P. Joy Ho, Derek McCulloch and Alison V. Todd. Their work appears in journals such as Blood, Pathology, British Journal of Haematology, American Journal of Hematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.